Court Opinion

ID: 2868002
Source: CourtListenerOpinion
Date Created: 2015-09-06 02:20:42.611925+00
Date Added: 2024-06-11T11:34:58.173675
License: Public Domain

TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

                                       NO.03-03-00577-CV

                                Trilogy Software, Inc., Appellant

                                                 v.

                      Callidus Software, Inc. and Yinghui Liu, Appellees

     FROM THE DISTRICT COURT OF TRAVIS COUNTY, 126TH JUDICIAL DISTRICT
           NO. GN-300650, HONORABLE PAUL DAVIS, JUDGE PRESIDING

                                          OPINION

               This is an intellectual property case that arose after appellee Yinghui Liu, who

formerly worked for appellant Trilogy Software, Inc., went to work for appellee Callidus Software,

Inc., one of Trilogy’s competitors. Trilogy filed a lawsuit alleging that Liu breached non-

competition and non-disclosure agreements with Trilogy and that Callidus tortiously interfered with

those agreements. Trilogy also alleged that both Callidus and Liu misappropriated Trilogy’s trade

secrets. The trial court granted summary judgment in favor of Callidus and Liu as to all of Trilogy’s

claims. We affirm in part and reverse and remand in part.
                                         BACKGROUND

               Trilogy, a software company, hired Liu, a computer programmer, in 1999. On his

first day of work, Trilogy asked Liu to sign a Proprietary Information Agreement (PIA). The

agreement was prefaced with the clause, “In connection with my employment by Trilogy Software,

Inc., I agree to the following,” followed by sixteen numbered paragraphs. Paragraph one set forth

several prohibitions against Liu’s use or disclosure of Trilogy’s proprietary information (hereinafter,

the “non-disclosure agreement”):

       Proprietary Information. I understand that my work as an employee of Trilogy will
       involve access to and creation of confidential (including trade secrets) and
       proprietary information (collectively “Proprietary Information”). I agree to keep all
       Proprietary Information in trust for the benefit of Trilogy. I will never use any
       Proprietary Information, except as required by my duties to Trilogy. I understand that
       this prohibition prevents me from discussing Proprietary Information, even in general
       terms, with persons outside Trilogy.

       “Proprietary Information” means information, ideas, and materials of or about
       Trilogy or its affiliates, employees, customers or others with whom Trilogy conducts
       business. Proprietary Information that is not generally known to the software
       industry or the public is confidential and I agree to exercise diligence at all times to
       maintain the confidentiality of all confidential Proprietary Information and not
       disclose confidential Proprietary Information. I understand that my obligation to
       keep Proprietary Information strictly confidential shall survive the termination of my
       employment and/or this agreement.

       Proprietary Information includes, without limitation, information, ideas or material
       of a technical nature such as research and development results, software design and
       specifications, source and object code, training and training materials, invention
       disclosures, patent applications and other materials and concepts relating to Trilogy’s
       products and processes. Proprietary Information also includes information, ideas, or
       materials of a business nature such as non-public financial information; information
       relating to profits, costs, marketing, strategy, purchasing, sales, customers, suppliers,
       contract terms, employees, and salaries, product development plans; business and
       financial plans and forecasts, and marketing and sales plans and forecasts.

                                                  2
Paragraph four of the PIA set forth various restrictions against Liu competing with Trilogy

(hereinafter, the “non-compete agreement”):

       Competing Business. . . . In consideration of Trilogy’s agreement to provide such
       Proprietary Information and such specialized training to me and my receipt of such
       Proprietary Information and training, and in the recognition of the value of such
       Proprietary Information and training to Trilogy, I agree that I will not, during and for
       a period of 24 months (if terminated without cause, then for a period of 12 months)
       following termination of my employment by Trilogy . . . [or] on my own behalf . . .
       engage in or render services to any person or entity engaged in any business in which
       Trilogy . . . is engaged, in any county or parish of any state in the United States or in
       any country or political subdivision of the world in which Trilogy . . . conducts such
       business.
       ...

Other provisions of note included paragraph five, which required Liu to immediately return all

property belonging to Trilogy and all material containing Proprietary Information upon termination

of his employment or “at any time it so requests.” Finally, paragraph fifteen provided:

       General. This is not an employment contract. Unless otherwise provided in an
       Employment Agreement between you and Trilogy, I understand that my employment
       is “at will” and nothing set forth in this Agreement shall prevent or limit my right to
       terminate my employment any time with or without notice, and Trilogy may
       terminate my employment at any time and for any reason without notice.

Liu signed the agreement on November 15, 1999. The PIA did not contain a blank in which a

Trilogy representative could sign the agreement, and no one from Trilogy signed it. It is undisputed

that later that same day, Trilogy gave Liu access to Proprietary Information and training.

                                                  3
               While at Trilogy, Liu worked as a technical consultant who customized versions of

a Trilogy data management software product, DMS, for use by various insurance companies. One

of those insurance companies was Aetna. Liu’s work involved customizing a version of DMS to

address Aetna’s unique business needs relating to its agent compensation system.1 This task required

Liu to both write new software and to identify functionality within the then-existing versions of

DMS that could satisfy the requirements. Liu also developed a project plan to move certain aspects

of Aetna’s compensation scheme to a more advanced version of DMS. Liu was the primary contact

for Aetna with regard to the technical aspects of Trilogy’s work.

               In December 2002, Callidus contacted Liu to inquire about the possibility of him

working for Callidus.     Although Liu responded by e-mailing a resume and discussing the

opportunity, Liu told Callidus that he was not interested in leaving Trilogy. On January 17, 2003,

however, Trilogy informed Liu that he would be laid off due to lack of work, and did so on January

21, 2003, although Liu remained on the payroll until February 21. Trilogy prepared an “Employment

Separation Agreement” (ESA) wherein it provided Liu with one month salary and allowed him to

remain on the payroll for that month in the interest of preserving Liu’s immigration status. The

Agreement also provided: “You agree to continue to comply with the terms of any non-competition

and non-disclosure/confidentiality agreement . . . .” The original PIA was stapled to the back of the

Separation Agreement. Liu signed the ESA on February 10, 2003.

       1
         Because much of the specific technological and proprietary information at issue in this case
has been filed under seal, our references are deliberately vague to preserve confidentiality.

                                                 4
               Upon being notified that he would be laid off, Liu sent out his resume to a number

of companies, including Callidus, Aetna, and Accenture, which provided consulting services to

Aetna. Callidus hired him in early February 2003. Callidus is a software company offering

compensation management software, TrueComp, that competed with Trilogy’s DMS. The summary

judgment record indicates that Callidus was attracted to Liu because of his “formidable technical and

domain strengths” and hired him with an eye to deploy him in the company’s effort to win Aetna’s

business.

               Having learned of Callidus’s employment of Liu, Trilogy filed this suit on February

28, 2003. It asserted the following claims against Liu:

       !    Breach of his non-disclosure agreement with Trilogy;

       !    Breach of his non-compete agreement with Trilogy;

       !    Misappropriation and “inevitable disclosure” of Trilogy’s trade secrets.

Against Callidus, Trilogy asserted the following claims:

       !    Tortious interference with Trilogy’s contractual rights under its confidentiality
            and non-compete agreements with Liu;

       !    Misappropriation and “inevitable disclosure” of Trilogy’s trade secrets.

Trilogy sought both damages and injunctive relief, as well as expedited discovery. On the same day,

the district court issued a temporary restraining order prohibiting Liu and Callidus from using or

disclosing Trilogy trade secrets or confidential information, soliciting certain customers of Trilogy,

                                                  5
or destroying any information relating to Trilogy trade secrets, confidential information, or Trilogy

products. However, the court refused to enforce the non-compete agreement. This temporary

restraining order was later extended by agreement of the parties.

                In March of 2003, Callidus won the Aetna account from Trilogy, and the “Aetna

project” whereby Callidus was to implement software to manage Aetna’s agent compensation system

was scheduled to begin in mid-April. Although there is no evidence that Liu was involved in the

sales effort to win this account, a team from Accenture involved with the planning for the project

requested his assistance. One of the Accenture employees on the project was Saied Karamooz, the

same Accenture consultant with whom Liu had worked on Aetna matters while at Trilogy.

                Liu explained in his deposition that the team drew “a very clear line” whereby he

would not be asked to divulge “anything which has anything to do with Trilogy software

implementation.” However, on March 10, Liu received an e-mail from one of the Accenture

employees on the team with roughly fifty files attached. The e-mail requested Liu to “[t]ake a look

at the attached files for some background on the project and on the ETL [extraction, transformation

and loading] portion specifically.” Trilogy asserts that several of these files contained its trade secret

information, including a spreadsheet that described the data model that Trilogy used in its DMS

product.

                In early April, Liu advised the Accenture team members, and later Callidus top

management, of various issues relating to the complexities of Aetna’s business systems that Liu felt

were not adequately addressed by the TrueComp product. This triggered additional work by Callidus

personnel to address those issues.

                                                    6
                Liu was deposed on April 8, 2003. As of that time, he had not worked directly with

Aetna personnel, but only with Accenture or Callidus employees. He described his job at Callidus

as “deploy[ing] Callidus’s software to an enterprise environment,” which entailed understanding

customer needs and how Callidus’s software can best address those needs. He denied that he would

be involved in pre-selling activities or in writing source code to customize Callidus products to

customer needs.

                On May 6 and 7, 2003, Callidus and Liu each filed a motion for summary judgment

as to all of Trilogy’s claims. A hearing was held on May 28 before the Honorable Paul Davis. Judge

Davis granted both motions at the conclusion of the hearing and signed an order to that effect on

August 18. Trilogy now appeals.

                                              ANALYSIS

                Trilogy asserts that the district court erred by granting summary judgment against

each of its claims. It presents six issues whose controlling legal questions can be grouped as follows:

(1) whether the non-compete agreement between Liu and Trilogy is enforceable;2 (2) whether the

evidence raises a fact issue as to whether Liu and Callidus have misappropriated Trilogy’s trade

        2
          This question controls our disposition of Trilogy’s first and second issues. In its first issue,
Trilogy complains that the trial court erred in granting summary judgment on its claim that Liu
breached the non-compete agreement. In its second issue, Trilogy complains of the trial court’s
summary judgment on its claim that Callidus tortiously interfered with the non-compete agreement.
Both issues turn on the enforceability of the non-compete obligations in the PIA and ESA. See
Juliette Fowler Homes, Inc. v. Welch Assocs., Inc., 793 S.W.2d 660, 665 (Tex. 1990) (tortious
interference claim cannot be predicated upon unenforceable non-compete clause).

                                                    7
secrets, or inevitably will;3 and (3) whether the trial court properly granted summary judgment as to

Trilogy’s claims that Liu breached his contractual non-disclosure obligations and that Callidus

tortiously interfered with those obligations.4

Standard of review

                Liu and Callidus each moved for summary judgment under both the traditional and

no-evidence standards.5

    Traditional summary judgment

                The standards for review of a traditional summary judgment are well established: the

movant must show that there is no genuine issue of material fact and that it is entitled to judgment

as a matter of law; in deciding whether there is a disputed material fact issue precluding summary

judgment, the court must take evidence favorable to the nonmovant as true; and the court must

indulge every reasonable inference in favor of the nonmovant and resolve any doubts in the

nonmovant’s favor. See Tex. R. Civ. P. 166a(c); Pustejovsky v. Rapid-Am. Corp., 35 S.W.3d 643,

645-46 (Tex. 2000); Nixon v. Mr. Prop. Mgmt. Co., 690 S.W.2d 546, 548-49 (Tex. 1985).

       3
         In issues five and six, Trilogy complains that the trial court erred in granting summary
judgment on Trilogy’s trade secret misappropriation claims against Liu and Callidus, respectively.
       4
          Issue three urges that the trial court erred in granting summary judgment on Trilogy’s claim
that Liu breached the non-disclosure agreement, while issue four complains of summary judgment
on Trilogy’s claim that Callidus tortiously interfered with that agreement.
       5
           See Binur v. Jacobo, No. 02-0405, 2004 WL 1048332, *3 (Tex. May 7, 2004).

                                                  8
    No-evidence summary judgment

               A party seeking a no-evidence summary judgment must assert that no evidence exists

as to one or more of the essential elements of the nonmovant’s claims on which it would have the

burden of proof at trial. Holmstrom v. Lee, 26 S.W.3d 526, 530 (Tex. App.—Austin 2000, no pet.).

Once the movant specifies the elements on which there is no evidence, the burden shifts to the

nonmovant to raise a fact issue on the challenged elements. Tex. R. Civ. P. 166a(i). To raise a

genuine issue of material fact, the nonmovant must set forth more than a scintilla of probative

evidence as to an essential element of the nonmovant’s claim on which the nonmovant would have

the burden of proof at trial. See id.; Merrell Dow Pharms., Inc. v. Havner, 953 S.W.2d 706, 711

(Tex. 1997). If the evidence supporting a finding rises to a level that would enable reasonable,

fair-minded persons to differ in their conclusions, then more than a scintilla of evidence exists.

Havner, 953 S.W.2d at 711. Less than a scintilla of evidence exists when the evidence is “so weak

as to do no more than create a mere surmise or suspicion” of fact, and the legal effect is that there

is no evidence. Jackson v. Fiesta Mart, 979 S.W.2d 68, 70 (Tex. App.—Austin 1998, no pet.)

(quoting Kindred v. Con/Chem, Inc., 650 S.W.2d 61, 63 (Tex. 1983)). If the nonmovant fails to

present evidence raising a genuine issue of material fact as to the challenged element, the trial court

must grant the motion. Tex. R. Civ. P. 166a(i). A no-evidence summary judgment is essentially a

directed verdict granted before trial, to which we apply a legal sufficiency standard of review.

Jackson, 979 S.W.2d at 70.

               The district court did not state the basis for its decision in either of its orders granting

summary judgment. When we review a summary judgment in which the trial court did not state the

                                                   9
basis for its decision in its order, the appealing party must show that it is error to base summary

judgment on any ground asserted in the motion. Star-Telegram, Inc. v. Doe, 915 S.W.2d 471, 473

(Tex. 1995). We must affirm the summary judgment if any one of the movant’s theories has merit.

Id. Because the propriety of a summary judgment is a question of law, we review the trial court’s

decision de novo. See Natividad v. Alexsis, Inc., 875 S.W.2d 695, 699 (Tex. 1994).

Enforceability of the non-compete agreement

               The enforceability of a covenant not to compete is a question of law. Light v. Centel

Cellular Co. of Tex., 883 S.W.2d 642, 644 (Tex. 1994); Alex Sheshunoff Mgt. Srv., L.P. v. Johnson,

124 S.W.3d 678, 684 (Tex. App.—Austin 2003, pet. filed). A covenant not to compete is a

disfavored contract in restraint of trade and is unenforceable unless it meets certain statutory

requirements. See Tex. Bus. & Com. Code Ann. §§ 15.05, .50 (West 2002); Sheshunoff, 124 S.W.3d

at 684. Those requirements are set forth in Section 15.50 of the Texas Business and Commerce

Code:

        A covenant not to compete is enforceable if it is ancillary to or part of an otherwise
        enforceable agreement at the time the agreement is made to the extent that it contains
        limitations as to time, geographical area, and scope of activity to be restrained that
        are reasonable and do not impose a greater restraint than is necessary to protect the
        goodwill or other business interest of the promisee.

Tex. Bus. & Com. Code Ann. § 15.50 (a). Section 15.50 thus imposes two threshold requirements

that a covenant not to compete must meet in order to be enforceable. The first is a two pronged test:

there must exist an otherwise enforceable agreement that must have existed at the time the non-

                                                 10
compete agreement is made. Second, the non-compete agreement must be ancillary to or part of that

“otherwise enforceable agreement.” We consider each requirement in turn.

    Otherwise enforceable agreement at the time the non-compete agreement is made

                For the requisite “otherwise enforceable agreement,” Trilogy points to Liu’s

non-disclosure obligations in the PIA. Under paragraph one of the PIA, Liu agreed to “keep all

Proprietary Information in trust for the benefit of Trilogy,” “never use any Proprietary Information,

except as required by [his] duties to Trilogy,” not to “discuss[] Proprietary Information, even in

general terms, with persons outside Trilogy,” and “to exercise diligence at all times to maintain the

confidentiality of all confidential Proprietary Information and not disclose confidential Proprietary

Information.”    These obligations, furthermore, were to “survive the termination of [Liu’s]

employment and/or this agreement.”

                Liu and Callidus do not dispute that Liu’s non-disclosure obligations under the PIA

are enforceable, but dispute whether they were enforceable at the time the non-compete agreement

was made, as required by Section 15.50. This issue turns on the nature of the consideration that

supports Liu’s non-disclosure obligations. Like any contract, the PIA must be supported by

consideration in order to be enforceable. Sheshunoff, 124 S.W.3d at 684. “Consideration is a

present exchange bargained for in return for a promise. It consists of either a benefit to the promisor

or a detriment to the promisee.” Id. (quoting Roark v. Stallworth Oil & Gas, Inc., 813 S.W.2d 492,

496 (Tex. 1991) (internal citations omitted)). Trilogy urges that the requisite consideration it

provided in exchange for Liu’s return promise not to disclose Trilogy’s Proprietary Information was

                                                  11
its “promise” under the PIA to provide Liu information and training. Under paragraph four of the

PIA, Liu acknowledged “Trilogy’s agreement to provide . . . Proprietary Information and . . .

specialized training.” Trilogy thus characterizes the PIA as a bilateral contract—a promise given in

exchange for a promise—each of which became enforceable when Liu signed the PIA.

               Liu and Callidus urge that Trilogy’s “promise” to provide Liu information and

training was illusory and thus unenforceable because Liu’s employment was indisputably at-will.

Standing alone, an at-will employment relationship cannot constitute an “otherwise enforceable

agreement” because neither the employer nor the employee are bound to continue the relationship;

each is free to discontinue employment in lieu of performance. Light, 883 S.W.2d at 644-45;

Sheshunoff, 124 S.W.3d at 684. For the same reasons, an “otherwise enforceable agreement” cannot

depend upon an additional period of at-will employment. Thus, as the supreme court observed in

Light, an employer’s promise of a raise to an at-will employee is illusory and unenforceable because

the obligation is dependant upon a period of continued employment, which the employer could avoid

by firing the employee. Light, 883 S.W.2d at 645 n.5. Likewise, a promise whose performance is

dependent upon continued at-will employment cannot serve as the consideration necessary to create

a bilateral contract comprising an “otherwise enforceable agreement.” Id. at 645.

               Because Trilogy could have avoided its “promise” under the PIA to provide

information and training to Liu merely by terminating Liu’s at-will employment relationship, it is

illusory and cannot serve as consideration supporting Liu’s non-disclosure obligations. Light, 883
S.W.2d at 645 n.5. Trilogy relies heavily on footnote 14 in Light for support of its proposition that

its “promise” to give Liu access to confidential information and training in the future was sufficient

                                                 12
consideration to support the non-disclosure agreement. Trilogy misreads footnote 14. The footnote

states in pertinent part: “If an employer gives an employee confidential and proprietary information

or trade secrets in exchange for the employee’s promise not to disclose them, and the parties enter

into a covenant not to compete, the covenant is ancillary to an otherwise enforceable agreement.”

Id. at 647 n.14 (emphasis added). Footnote 14 thus contemplates not a bilateral contract, but a

unilateral contract in which the employer’s provision of confidential information comprises

consideration for the employee’s non-disclosure obligations. As the supreme court noted elsewhere

in Light:

       If only one promise is illusory, a unilateral contract can still be formed; the
       non-illusory promise can serve as an offer, which the promisor who made the illusory
       promise can accept by performance. For example, suppose an employee promises
       not to disclose an employer’s trade secrets and other proprietary information, if the
       employer gives the employee such specialized training and information during the
       employee’s employment. If the employee merely sought a promise to perform from
       the employer, such a promise would be illusory because the employer could fire the
       employee and escape the obligation to perform. If, however, the employer accepts
       the employee’s offer by performing, in other words by providing the training, a
       unilateral contract is created in which the employee is now bound by the employee’s
       promise.

Id. at 647 n.6 (citing E. Allan Farnsworth, Contracts 72-82 (1982)) (citations omitted); see also

Sheshunoff, 124 S.W.3d at 687 (“ASM’s acceptance of Johnson’s promise to maintain

confidentiality by later providing confidential information created a unilateral contract”).

               The same happened here. Liu and Callidus do not dispute that Trilogy’s provision

of information and training as contemplated under the PIA gave rise to a unilateral contract binding

Liu to his non-disclosure obligations under that agreement. Trilogy urges in the alternative that this

                                                 13
unilateral contract comprises the requisite “otherwise enforceable agreement at the time the

agreement is made.” We disagree. It is undisputed that Trilogy provided the information and

training not “at the time the agreement was made,” but only at a later time. See Tex. Bus. & Com.

Code Ann. § 15.50 (a); Light, 883 S.W.2d at 645 n.6; Sheshunoff, 124 S.W.3d at 687 (distinguishing

between unilateral contract created by performance and otherwise enforceable agreement at time

agreement was made); Olander v. Compass Bank, 172 F. Supp. 2d 846, 854 (S.D. Tex. 2001).6

               In the further alternative, Trilogy argues that the ESA that Liu signed when leaving

Trilogy, which incorporates the terms of the PIA, constitutes an “otherwise enforceable agreement

at the time the agreement is made.” At the time that Liu signed the ESA, the non-disclosure

agreement, as discussed above, was an “otherwise enforceable agreement” because Trilogy had

accepted Liu’s offer (promising not to disclose) by performance (providing training and

information). Furthermore, the ESA itself is a binding agreement made at the time the non-compete

agreement was concurrently made within it. However, the question remains whether the non-

compete agreement was ancillary either to the non-disclosure agreement or to the ESA at the time

either agreement was made and whether there was any consideration for Liu’s agreement in the ESA

not to compete.

       6
           Trilogy points out practical problems potentially created by a strict reading of Section
15.50’s requirement of an “otherwise enforceable agreement at the time the agreement is made.”
For example, even a momentary pause between Liu’s signature and Trilogy’s provision of
information and training could conceivably preclude enforcement of the non-compete agreement.
We are obligated to apply the statute the legislature has enacted. In any event, there is no evidence
that Trilogy provided Liu with confidential information immediately upon or only momentarily after
he signed the agreement; instead, the event occurred later that day.

                                                 14
    Ancillary to an otherwise enforceable agreement

               Under the ESA, Trilogy promised to pay Liu the equivalent of one month’s salary in

exchange for various promises by Liu, including his reaffirmation of his non-disclosure and non-

compete promises. We find that although the ESA was an enforceable contract, it was not of the

kind to which a non-competition agreement may be ancillary. We again follow the supreme court’s

analysis in Light:

       [I]n order for a covenant not to compete to be ancillary to an otherwise enforceable
       agreement between employer and employee:

       (1) the consideration given by the employer in the otherwise enforceable agreement
           must give rise to the employer’s interest in restraining the employee from
           competing; and

       (2) the covenant must be designed to enforce the employee’s consideration or return
           promise in the otherwise enforceable agreement.

Light, 883 S.W.2d at 647. The Light court stated, “[t]he otherwise enforceable agreement must give

rise to the ‘interest worthy of protection’ by the covenant not to compete.” Id. The court cited

DeSantis v. Wackenhut Corp., 793 S.W.2d 670, 682 (Tex. 1990), which in turn cited to section 187,

comment b of the Restatement of Contracts, noting that business goodwill and confidential or

proprietary information are examples of such worthy interests. Id. Our sister court in Dallas has

interpreted this language in Light to mean that a pecuniary interest or a promise by an employer to

give notice before termination are not interests worthy of a non-competition covenant. Strickland

v. Meditronic, Inc., 97 S.W.3d 835, 839 (Tex. App.—Dallas 2003, pet. dism’d w.o.j) (“Medtronic’s

consideration is the promise to give ninety days notice prior to terminating without cause and the

                                                15
promise to compensate Strickland in the event of economic hardship resulting from the non-compete

agreement. Such promises do not give rise to an interest worthy of protection by a covenant not to

compete.”).

               This Court has previously come to a similar conclusion: “ASM’s non-illusory

promise to give at least two weeks’ notice before terminating Johnson does not give rise to its

interest in restraining Johnson from competing.” Sheshunoff, 124 S.W.3d at 687. In this case, Liu

was allowed to stay on Trilogy’s payroll for an extra month to preserve his immigration status.

Although the consideration in this case is more substantial than that in Sheshunoff, we conclude that

the one month of employment promised in the ESA does not give rise to Trilogy’s interest in

restraining Liu from competing and, therefore, is not an “interest worthy of protection” by the

covenant not to compete. See Light, 883 S.W.2d at 647.

               As to the non-disclosure agreement, although it serves as an “otherwise enforceable

agreement” at the point in time that Liu reaffirmed the non-competition covenant within the ESA,

and the interest of preserving the confidentiality of information is an interest worthy of protection

by a covenant not to compete, there is a separate problem of consideration for Liu’s reaffirmation

of his promise. Trilogy’s past provision of proprietary information and specialized training would

be past consideration and therefore not competent consideration for contract formation. See

Sheshunoff, 124 S.W.3d at 687. When we evaluate the ESA at the time it was made, Trilogy’s

provision of confidential information and training to Liu before signing the agreement will not

support its promises in the agreement. Roark, 813 S.W.2d at 496 (“Consideration is a present

exchange bargained for in return for a promise.”); see also Jordan Leibman & Richard Nathan, The

                                                 16
Enforceability of Post-employment Noncompetition Agreements Formed After At-Will Employment

Has Commenced: the “Afterthought” Agreement, 60 S. Cal. L. Rev. 1465, 1528-29 (1987) (“If

anything in the classical law of contracts is clear, it is that past consideration is not good

consideration. Any exchange has to be contemporaneous by definition, because the promise and the

consideration for that promise must serve as reciprocal conventional inducements.”); see also

Sheshunoff, 124 S.W.3d at 687.

               In this case, the only proffered consideration was the financial incentives that were

offered to Liu in ESA. However, as we have noted, financial benefits do not give rise to an “interest

worthy of protection” by the covenant not to compete. Sheshunoff, 124 S.W.3d at 687; see also

Strickland, 97 S.W.3d at 839. Therefore, we hold that the non-compete agreement was not

enforceable and overrule Trilogy’s first and second issues.7

Trade secret misappropriation

               Misappropriation of trade secrets is a common-law tort cause of action. The elements

of misappropriation are: (1) existence of a trade secret; (2) breach of a confidential relationship or

improper discovery of a trade secret; (3) use of the trade secret; and (4) damages. IBP, Inc. v.

       7
           Liu and Callidus also urged that the non-compete agreement was also unenforceable
because it exceeded Section 15.50’s geographic scope restrictions. Tex. Bus. & Com. Code Ann.
§ 15.50 (West 2002). Trilogy disagrees, and urges that even if the non-compete agreement is
overbroad, we would be required to reverse the trial court and remand for a reformation. Id.
§ 15.51(c) (West 2002). Because we hold that the non-compete agreement fails to satisfy Section
15.50’s threshold requirements that it be “ancillary to or part of an otherwise enforceable agreement
at the time the agreement is made,” we need not reach this ground.

                                                 17
Klumpe, 101 S.W.3d 461, 476 (Tex. App.—Amarillo 2001, pet. denied) (citing Taco Cabana Int’l

v. Two Pesos, Inc., 932 F.2d 1113, 1123 (5th Cir. 1991)). A “trade secret”

       may consist of any formula, pattern, device or compilation of information which is
       used in one's business, and which gives him an opportunity to obtain an advantage
       over competitors who do not know or use it. It may be a formula for a chemical
       compound, a process of manufacturing, treating or preserving materials, a pattern for
       a machine or other device, or a list of customers.

                                                ***

       A trade secret is a process or device for continuous use in the operation of the
       business. Generally it relates to the production of goods, as, for example, a machine
       or formula for the production of an article.

Hyde Corp. v. Huffines, 314 S.W.2d 763, 777 (Tex. 1958) (quoting Restatement of Torts § 757).

“Use” of a trade secret means commercial use, by which a person seeks to profit from the use of the

secret. Atlantic Richfield Co. v. Misty Prods., Inc., 820 S.W.2d 414, 421 (Tex. App.—Houston [14th

Dist.] 1991, writ denied).

               Trilogy raises three arguments challenging the trial court’s granting of summary

judgment against its trade secret misappropriation claim. We can quickly dispose of two. First,

Trilogy argued in the trial court and in its briefing that if Liu and Callidus have not already

misappropriated its trade secrets, they would “inevitably” do so in the course of Liu’s work.

However, Trilogy’s counsel conceded at oral argument that, due to the passage of time, this case is

no longer one to which the “inevitable disclosure” doctrine, if recognized in Texas, would apply.8

       8
          Trilogy also concedes in its briefing that “[c]ourts applying Texas law have recognized
inevitable misappropriation as an appropriate basis for an injunction against former employees . . . .”

                                                  18
               Second, Trilogy urges that the trial court abused its discretion in refusing to continue

the summary judgment hearing to enable it to obtain additional discovery on its misappropriation

claims. In support, Trilogy cites an affidavit from its attorney stating merely that certain of its

discovery requests were still outstanding—and nothing more. We reject Trilogy’s argument because

its affidavit does not explain why it needs this discovery, as required by Tex. R. Civ. P. 166a(g), nor

has it filed a verified motion for continuance under Tex. R. Civ. P. 252. See Tenneco Inc. v.

Enterprise Prod. Co., 925 S.W.2d 640, 647 (Tex. 1996).9 The trial court did not abuse its discretion

in proceeding to rule on Liu’s and Callidus’s summary judgment motions.

               Trilogy’s third argument is that the summary judgment evidence, as developed before

the summary judgment hearing, presented a fact issue as to whether Liu or Callidus had already used

Trilogy trade secrets in the development of the TrueComp product. It points to two pieces of

evidence. First, Trilogy references a March 10, 2003, e-mail Liu received from one of the Accenture

team members assigned to the prospective Aetna deployment, Stephen Shohen. Second, Trilogy

points to Liu’s involvement in identifying issues related to implementing TrueComp in Aetna’s

business environment.

(Emphasis added.) See also Cardinal Health Staffing Network, Inc. v. Bowen, 106 S.W.3d 230, 242
(Tex. App.—Houston [1st Dist.] 2003, no pet.) (“We have found no Texas case expressly adopting
the inevitable disclosure doctrine . . . .”).
       9
          In fact, Trilogy did not explicitly seek a continuance in writing, either in a separate motion
or in its summary judgment response. Instead, it merely urged, in a footnote to its summary
judgment response, that its assertions regarding trade secret misappropriation should not be
considered to be exhaustive because discovery was still ongoing.

                                                  19
    The Accenture e-mail

               This e-mail was sent around the time Liu completed his initial training at Callidus.

During the morning of March 10, Shohen e-mailed Liu to “touch base” so they could begin

preliminary work preparing for the possible deployment of TrueComp at Aetna. Shohen had noted

that much of the preliminary work would involve design of the inbound and outbound interfaces

through which data would be moved, as well as “some Comp Plans work which you will also be able

to help us with.” Later that same day, Shohen sent Liu the e-mail in question. Shohen asked Liu to

“[t]ake a look at the attached files for some background on the project and on the ETL [extraction,

transfer, and loading] portion specifically.” Shohen attached to the e-mail approximately fifty

documents in five ZIP files. Trilogy specifically identifies only one document that it claims

contained its trade secrets, a spreadsheet that describes the data model or schema that Trilogy used

in its DMS product. Liu and Callidus do not dispute that these files contained Trilogy trade secret

information but dispute whether there is any evidence that either used this information. We agree

with Liu and Callidus that Trilogy has not raised a fact issue as to whether Liu or Callidus used any

of the ZIP files in their work on the TrueComp product.

               Trilogy offers no explanation or proof regarding whether or how Liu or Callidus used,

or could have used, Trilogy’s DMS data schema in their work on the TrueComp deployment.

Rather, it urges that Liu’s mere receipt of the e-mail from an Accenture consultant asking him to

“take a look” is circumstantial proof that he did, in fact, (1) look at the information and (2) somehow

use it in his work to benefit Callidus. Inferences stacked only upon inferences is no evidence. See,

e.g., Marathon Oil Co. v. Pitzner, 106 S.W.3d 724, 728 (Tex. 2003). In fact, there is uncontroverted

                                                  20
summary judgment evidence—specifically, the deposition testimony of Callidus’s Betty Costa, in

response to questioning by Trilogy’s counsel—that Trilogy’s DMS data schema had nothing to do

with product design or how a product uses the data, and she did not see how it could be used to a

competitive advantage. Trilogy made no attempt to controvert this evidence or otherwise explain

how Liu or Callidus used Trilogy’s data schema, such as it might have done through Liu, Trilogy

witnesses, or expert testimony. Standing alone, Liu’s receipt of the e-mail from Shohen does not

raise a genuine issue of material fact that he or Callidus actually used Trilogy’s trade secrets in their

initial work on the TrueComp deployment.

     Identifying implementation issues

                Trilogy also relies on evidence of Liu’s proficiency in identifying issues that Callidus

would need to address in adapting TrueComp to the complexities in Aetna’s business system. The

summary judgment record illustrates that in late March, Liu and Accenture’s Shohen were working

together on developing the Aetna “Comp Plan.” The two discussed via e-mail an issue relating to

which Aetna business variables best corresponded with TrueComp data fields, and Liu discussed this

issue with Paul Devlin of Callidus’s Advanced Technology Group. By March 27, Liu had prepared

a preliminary version of the Comp Plan, which he e-mailed to Shohen with a notation indicating

there were complications in his analysis. Sometime around April 1, Liu and Shohen discussed these

complications with Saied Karamooz, a more senior Accenture consultant. This prompted Karamooz

to send Liu an e-mail expressing alarm that the issues had not previously been addressed and urging

Liu to “engage the right technical experts to determine the most optimal approach for handling

                                                   21
Aetna’s requirements.” Karamooz copied Brian Burkhart, Callidus’s managing director for eastern

sales, who e-mailed Liu to request that Liu send him his concerns so they could get executive level

attention. Liu responded with a list of “several basic requirements which can’t be addressed by the

stock product.” The list included the issue Liu had previously discussed with Devlin, as well as

several other issues. Burkhart obtained feedback from Callidus executives, which referred Liu to

David Kelly. Liu requested help from Kelly. Meanwhile, Liu examined the TrueComp sales

document and model product that Callidus’s sales personnel had presented at Aetna and advised

Bryan Burkhart that “they didn’t capture the difficult issues that I raised in my earlier e-mail.” Later

the same day, Kelly responded to Liu’s request for help, making a suggestion regarding how Liu

could draw upon existing functionality in the TrueComp product to address one issue. On the

following day, Kelly e-mailed Liu, Karamooz, and Shohen, copied to Callidus executives, a

document “with some ideas for possible solutions for the specific issues raised regarding the Aetna

broker comp plan.”

               Trilogy urges that the foregoing sequence of events raises a fact issue as to whether

Liu or Callidus misappropriated Callidus trade secrets in planning the deployment of TrueComp to

Aetna’s business environment. In its pleadings and during discovery, Trilogy claimed trade secret

protection for the specific solutions it devised to address “the difficulties inherent in implementing

a compensation-management system meeting Aetna’s requirements while coping with the

complexities of its compensation system.” But Trilogy does not now claim that Callidus or Liu

misappropriated its specific solutions or technology when devising solutions of their own, except

                                                  22
in one very broad respect: Trilogy claims that Liu’s mere knowledge of a solution devised by

Trilogy made easier the discovery of Callidus’ distinct, alternative solutions.10

               Trilogy cites no authority to support this theory of trade secret protection. Absent

further guidance from the Texas Supreme Court, we decline to extend Texas trade secret protections

so broadly. Furthermore, Trilogy’s own summary judgment evidence indicates that it was Kelly, not

Liu, who devised Callidus’ solutions to the TrueComp deployment issues. Trilogy points to no

evidence that Liu was involved in developing those solutions, much less that he misappropriated

Trilogy trade secrets in the process. Instead, Liu’s role appears to have been limited merely to

identifying the issues presented by Aetna’s business environment.

               Trilogy also attempts to claim trade secret protection for Liu’s knowledge of the

issues themselves. As Trilogy observes, information that a firm compiles regarding its customers

may enjoy trade secret status under Texas law. Huffines, 314 S.W.2d at 777 (quoting Restatement

of Torts § 757) (trade secrets may include any “compilation of information which is used in one's

business, and which gives him an opportunity to obtain an advantage over competitors who do not

know or use it,” and “may be . . . a list of customers.”); T-N-T Motorsports, Inc. v. Hennessey

Motorsports, Inc., 965 S.W.2d 18, 22 (Tex. App.—Houston [1st Dist.] 1998, no pet.) (“Items such

as customer lists, pricing information, client information, customer preferences, buyer contacts . .

       10
           Trilogy relies on deposition testimony of its corporate representative, who opined that “the
concept of the misappropriation of trade secrets has to do with solving the same problem, as opposed
to using the same technology” and “it’s just sort of a well understood concept of computer science
that there’s lots of ways to solve these problems, but once you’ve got one solution, the rest are much
easier to find.”

                                                  23
. have been shown to be trade secrets.”); Rugen v. Interactive Bus. Sys., Inc., 864 S.W.2d 548, 552

(Tex. App.—Dallas 1993, no writ) (customer lists and identities of clients and prospective clients

could be trade secrets).11 But this does not mean that trade secret status automatically attaches to any

information that a company acquires regarding its customers; if it did, it would amount to a de facto

common law non-compete prohibition.

               Before information can be a “trade secret,” there must be a substantial element of

secrecy. American Precision Vibrator Co. v. National Air Vibrator Co., 764 S.W.2d 274, 276 (Tex.

App.—Houston [1st Dist.] 1988, no writ). “Secrecy” in this sense is not limited solely to

confidentiality, but also requires that the information “is not generally known or readily ascertainable

by independent investigation.” Rugen, 864 S.W.2d at 552; Allan J. Richardson & Assocs., Inc. v.

       11
             Trilogy also cites several trade secret misappropriation cases that are clearly
distinguishable from the facts before us. See Computer Ass’n Int’l, Inc. v. Altai, Inc., 918 S.W.2d
453, 455 (Tex. 1996); Gonzales v. Zamora, 791 S.W.2d 258, 265 (Tex. App.—Corpus Christi 1990,
no pet.); Metallurgical Indus., Inc. v. Fourtek, Inc., 790 F.2d 1195, 1200-01 (5th Cir. 1986)
(interpreting Texas law); FMC Corp. v. Varco Int’l, Inc., 677 F.2d 500, 502-03 (5th Cir. 1982)
(same). In Altai, the defendant took copies of highly confidential source code from the plaintiff
employer and the evidence showed that the defendant’s new employer had used the source code in
its own systems. 918 S.W.2d at 455. In Gonzales, evidence indicated that the defendant, a former
employee of the plaintiff, took and used forms that had been created by the plaintiff, and that no
other company possessed at the time, in the defendant’s competing business. 791 S.W.2d at 262.
In Fourtek, Inc., defendants, in the course of a business deal, saw modifications that the plaintiff had
engineered to a zinc reclaiming furnace. 790 F.2d at 1197. The defendants then formed a company
on their own and began selling furnaces equipped with the exact same modifications. Id. at 1198.
In FMC, the court enjoined the plaintiff’s former employee from working for the plaintiff’s
competitor because it was shown that the competitor had tried to engineer a duplicate of the
plaintiff’s product but had been unable to do so and that the competitor had “historically copied
FMC’s products where it could because it was the least expensive way to compete.” 677 F.2d at
501. The employee that the competitor had sought to employ was the engineering manager of the
product that the competitor could not duplicate. Id. at 500-01.

                                                  24
Andrews, 718 S.W.2d 833, 837 (Tex. App.—Houston [14th Dist.] 1986, no writ) (emphasis added).

“When money and time are invested in the development of a procedure or device which is based on

an idea which is not new to a particular industry, and when that certain procedure or device is not

generally known, trade secret protection will exist.” Gonzales, 791 S.W.2d at 264. However,

information generally known and readily available is not protectable. Id. Consistent with this

concept of secrecy, a former employee may use the general knowledge, skills, and experience

acquired during employment to compete with a former employer. T-N-T Motorsports, 965 S.W.2d

at 22; Gonzales, 791 S.W.2d at 267. “It is . . . the burden of the party claiming secrecy status to

prove secrecy”—or in this case, provide more than a scintilla of evidence to support its claims.

Stewart & Stevenson Services, Inc. v. Serv-Tech, Inc., 879 S.W.2d 89, 99 (Tex. App.—Houston

[14th Dist.] 1994, writ denied) (citing Richardson v. Andrews, 718 S.W.2d 833 (Tex.

App.—Houston [14th Dist.] 1986, no writ).

                Trilogy has failed to meet this burden with regard to its claim of trade secret

protection for knowledge of “the difficulties inherent in implementing a compensation-management

system meeting Aetna’s requirements while coping with the complexities of its compensation

system.” There is no evidence that these difficulties are not readily ascertainable to someone with

Liu’s general knowledge, experience and skill set,12 and there is uncontroverted evidence that Aetna

disclosed the inner workings of its compensation system to both Callidus and Accenture. Liu’s

general knowledge of the issues presented by a customer’s compensation system, moreover, stands

       12
            Trilogy acknowledges that no one with Liu’s credentials had worked at Callidus before
Liu.

                                                25
in sharp contrast to the types of customer information that have been held to comprise trade secrets,

which characteristically have been compiled over long periods of time, through use of substantial

resources, and are shown to provide a competitive advantage. See T-N-T Motorsports, 965 S.W.2d

at 22-23 (customer database, which contained names, addresses, telephone numbers, types of

vehicles customers owned, birthdays and e-mail addresses, had been compiled over four years); H.E.

Butt Grocery Co. v. Moody’s Quality Meats, Inc., 951 S.W.2d 33, 39 (Tex. App.—Corpus Christi

1997, writ denied) (court reversed trial court’s judgment that marinade recipe was trade secret based

on evidence that recipe was not uncommon in industry and had been previously published).13

               Trilogy has failed to meet its burden of raising a genuine issue of material fact in

response to Liu and Callidus’s “no evidence” summary judgment motions to support its trade secret

misappropriation claims. We overrule Trilogy’s fifth and sixth issues.

Claims regarding the non-disclosure agreement

               Trilogy asserts that the trial court erred in two ways when granting summary judgment

on its claims that Liu breached the non-disclosure agreement and that Callidus tortiously interfered

with that agreement. First, Trilogy urges that neither defendant sought summary judgment on its

       13
           See also De Santis v. Wackenhut, Corp., 793 S.W.2d 670, 684 (Tex. 1990) (non-compete
agreement was unnecessary to protect information regarding identity of employer’s customers, and
“their special needs and requirements” where employer failed to show “that its customers could not
readily be identified by someone outside its employ, that such knowledge carried some competitive
advantage, or that its customers’ needs could not be ascertained simply by inquiry addressed to those
customers themselves.”).

                                                 26
claim that Liu breached the non-disclosure agreement.14 Trilogy draws two conclusions from this

asserted omission. As to Liu, Trilogy asserts that the trial court erred in granting summary judgment

on a ground not raised in Liu’s motion. See Tex. R. Civ. P. 166a(c); Science Spectrum, Inc. v.

Martinez, 941 S.W.2d 910, 912 (Tex. 1997). As to Callidus, Trilogy argues that Callidus cannot

dispute for purposes of summary judgment that Liu breached the non-disclosure agreement, and must

rely solely on the ground that it did not commit a “willful act of interference.”

               Trilogy’s second complaint is that evidence raised fact issues regarding both Liu’s

breach of the non-disclosure agreement and Callidus’s willful interference with it. As concerning

Liu’s alleged breach, Trilogy points to the same evidence on which it relied regarding its

misappropriation claims.

               We agree with both of Trilogy’s arguments concerning these claims against Liu. We

also agree that the evidence raises a fact issue regarding whether Callidus tortiously interfered with

Liu’s non-disclosure obligations.

    Scope of Liu’s summary judgment motion

               As his “Bases for Summary Judgment,” Liu asserted that he was entitled to summary

judgment on each of three sets of grounds, which he listed as headings: “Trilogy’s claim for breach

of contract,” “Trilogy’s claim of misappropriation of trade secrets,” and “Trilogy’s claim of

       14
           Trilogy also argues that neither defendant sought summary judgment on the ground that
the non-disclosure agreement is unenforceable, and that the trial court would have erred in granting
summary judgment on that ground. As noted previously, neither Liu nor Callidus appear to dispute
that the non-disclosure agreement is enforceable.

                                                 27
inevitable disclosure of trade secrets.” Under the breach of contract heading, Liu asserted only two

grounds:

       1.   Liu’s covenant not to compete is unenforceable as a matter of law because it is
            not ancillary to an otherwise enforceable agreement at the time the agreement
            was made.

       2.   Even if the covenant not to compete were ancillary to an otherwise enforceable
            agreement, Liu’s covenant not to compete is unenforceable as a matter of law
            because it is not reasonably limited so as to impose no greater restraint than is
            necessary to protect the legitimate business interests, if any, of Trilogy.

Liu makes no reference in this section of his motion to Trilogy’s claim for breach of the non-

disclosure agreement, nor does he incorporate by reference arguments made elsewhere in the motion.

               Liu responds that Trilogy’s argument is “disingenuous” because he asserted in the

“misappropriation of trade secret” section of his motion that “Trilogy has presented no evidence that

Liu has misused any confidential information of Trilogy, let alone any information that would

constitute a trade secret.” Liu thus suggests that this ground, as it relates to “confidential

information,” is substantively identical to an assertion that there is no evidence Liu breached the non-

disclosure agreement, and that this was sufficient to satisfy the requirements of Tex. R. Civ. P.

166a(c). We disagree for two reasons.

               First, Liu’s assertion that there is no evidence of misuse of “confidential information”

is narrower than an assertion that there is no evidence Liu breached his non-disclosure obligations

under the PIA. Certain of the non-disclosure obligations of the PIA extend not only to trade secrets

or “confidential” information, but also to some non-confidential “proprietary information.”

                                                  28
               Second, even if Liu’s summary judgment ground that “Trilogy has presented no

evidence that Liu has misused any confidential information of Trilogy” is substantively equivalent

to a contention that Trilogy presented no evidence that Liu breached his non-disclosure obligations,

Liu failed to properly assert this ground as against Trilogy’s breach of contract claim. The Texas

Supreme Court, consistent with the strict view of Rule 166a(c) it has espoused in recent years,15 has

previously rejected a similar attempt to “bootstrap” a summary judgment ground regarding a claim

from one asserted elsewhere in the motion regarding a different claim. See Johnson v. Brewer &

Pritchard, P.C., 73 S.W.3d 193, 203-04 (Tex. 2002).

               Brewer & Pritchard, a law firm, sued Chang, a former associate, and Johnson, another

lawyer with whom Chang formed a partnership, for breach of fiduciary duty, actual and constructive

fraud, conversion, and negligence after Chang allegedly profited from assisting a potential client of

the firm in finding counsel outside the firm. Chang and Johnson moved for summary judgment

against the firm’s breach of fiduciary duty claims on the sole ground that Chang did not owe any

fiduciary obligation to the firm. The supreme court rejected this ground, holding that Chang and

Johnson owed a fiduciary duty not to profit or gain from assisting the potential client in finding

counsel other than the firm. Id. Of importance here, Chang and Johnson had also asserted elsewhere

in its motion summary judgment grounds in regard to other claims that were substantively identical

to an assertion that Chang did not breach his fiduciary duty. Id. Nonetheless, the supreme court held

       15
          E.g., McConnell v. Southside Indep. Sch. Dist., 858 S.W.2d 337, 339-41 (Tex. 1993) (“A
motion for summary judgment must stand or fall on the grounds expressly presented in the
motion.”).

                                                 29
that “Johnson and Chang were not entitled to summary judgment on the basis of no breach of

fiduciary duty because they did not include that ground in their motion.” Id. at 204. It reasoned that

Chang and Johnson “did not make these arguments in connection with the breach of fiduciary duty

claim,” “the sections of the motion dealing with those claims” where the arguments were made “was

[sic] not incorporated by reference or otherwise mentioned in the section that dealt with fiduciary

duty,” and they did not incorporate by reference evidence they cited in a “Procedural Background”

that would have supported that ground. Id. at 203-04.

               Liu’s summary judgment motion suffers from the same faults in regard to Trilogy’s

breach of non-disclosure agreement claim. Although Liu asserted in regard to the trade secret

misappropriation claim the ground that no evidence exists that he disclosed confidential information,

Liu did not make this argument in regard to the breach of contract claims, nor did he incorporate by

reference the grounds he asserted elsewhere. We are thus compelled to hold that the trial court erred

in granting summary judgment against Trilogy on its claims that Liu breached his non-disclosure

obligations. Furthermore, as we hold below, there is a fact issue as to whether Liu breached his non-

disclosure obligations.

    Callidus’s summary judgment motion

               Callidus’s summary judgment motion was largely parallel to Liu’s. Like Liu, Callidus

did not explicitly move for summary judgment on the ground that there is no evidence Liu breached

his non-disclosure obligations. However, Callidus did move for summary judgment on Trilogy’s

tortious-interference claim on the additional ground that “Trilogy has presented no evidence of a

                                                 30
 willful act of interference by Callidus.”16 Trilogy and Callidus dispute how broadly this summary

 judgment ground extends and whether Trilogy raised a fact issue regarding it.17 We will assume for

         16
           Under the heading “Callidus Is Entitled to Summary Judgment on Trilogy’s Claims of
 Tortious Interference With Contract,” it asserted the following three grounds:

              1.   Callidus cannot be liable for tortious interference with Liu’s covenant not
                   to compete is unenforceable as a matter of law and therefore cannot form
                   the basis of a claim of tortious interference.

              2.   Even if the covenant not to compete were ancillary to an otherwise
                   enforceable agreement, Callidus cannot be liable for tortious interference
                   with Liu’s covenant not to compete because it is unenforceable as a matter
                   of law because it is not reasonably limited so as to impose no greater
                   restraint than is necessary to protect the legitimate business interests, if
                   any, of Trilogy.

              3.   Trilogy has presented no evidence of a willful act of interference by
                   Callidus.

 Like Liu, Callidus asserts in a “misappropriation of trade secret” section of its motion that “Trilogy
 has presented no evidence that Liu has misused any confidential information of Trilogy, let alone
 any information that would constitute a trade secret.”
         17
             The elements of tortious interference with an existing contract are: (1) that a contract
 subject to interference exists; (2) that the alleged act of interference was willful and intentional; (3)
 that the willful and intentional act proximately caused damage; and (4) that actual damage or loss
 occurred. See, e.g., ACS Investors, Inc. v. McLaughlin, 943 S.W.2d 426, 430 (Tex. 1997); New York
 Life Ins. Co. v. Miller, 114 S.W.3d 114, 125 (Tex. App.—Austin 2003, no pet.). Callidus’s summary
 judgment ground that “Trilogy has presented no evidence of a willful act of interference by Callidus”
 references the second element. Trilogy characterizes this summary judgment ground and the “act
 of interference” element as concerning only whether Callidus sought to induce Liu to breach his non-
 disclosure obligations, not whether Liu in fact breached those obligations. Whether Liu actually
 breached those obligations, Trilogy contends, goes to the third element, proximate cause. Hence,
 Trilogy extrapolates, the sole issue raised by Callidus’s summary judgment motion regarding tortious
 interference is whether there is a fact issue regarding whether Callidus willfully and intentionally
 attempted to induce Liu to breach his non-disclosure obligations.

           To raise a fact issue on the issue of inducement, so defined, Trilogy points to evidence that
Callidus originally contacted Liu while he was still working at Trilogy, that Callidus hired him with

                                                     31
purposes of our analysis that, as Callidus contends, the controlling issue is whether the summary

judgment evidence raises a fact issue regarding whether Liu breached his non-disclosure obligations.

We hold that it does.

                Liu’s non-disclosure obligations under the PIA are not limited solely to protection

of trade secrets.18 “Proprietary Information,” as noted previously, includes “information, ideas, and

materials of or about Trilogy or its . . . customers, or others with whom Trilogy conducts business,”

as well as “information, ideas, or materials of a business nature such as . . . information relating to

. . . customers.” Liu agreed “to keep all Proprietary Information in trust for the benefit of Trilogy”

the intent to deploy him on the Aetna account, and that Callidus placed Liu in a key role on the Aetna
account a short time after he began work for the company. Furthermore, Trilogy points out that over
a year before Callidus initiated contact with Liu, Trilogy had sent a letter to Callidus’s general
counsel, in response to Callidus’s hiring of a former Trilogy employee, warning that former Trilogy
employees “are still subject to the confidentiality and non-solicitation obligations agreed to by each
employee when accepting employment with Trilogy.” Attached to the letter was a version of the PIA
containing non-disclosure obligations similar to the one Liu later signed.

           Callidus disagrees, contending that its summary judgment ground and the “act of
interference” element subsume the issue of whether Liu breached his non-disclosure obligations. See
Paul Mitchell Sys. v. Randall’s Food Mkts., Inc., 17 S.W.3d 721, 731 (Tex. App.—Austin 2000, pet.
denied) (“A party must be more than a willing participant” to “interfere” with contract; “it must
knowingly induce one of the contracting parties to breach its obligations.”).

           We need not address this rather ethereal legal issue because, as discussed above, we agree
with Trilogy’s alternative argument that the evidence raises a fact issue as to whether Liu breached
his non-disclosure obligations.
        18
          See Simplified Telesys., Inc. v. Live Oak Telecom, L.L.C., 68 S.W.3d 688, 692-93 (Tex.
App.—Austin 2000, no pet.) (status of information as trade secret did not govern whether party
breached confidentiality agreement that was not limited solely to trade secret information).

                                                  32
and “never use any Proprietary Information, except as required by my duties to Trilogy.” He also

acknowledged his understanding “that this prohibition prevents me from discussing Proprietary

Information, even in general terms, with persons outside Trilogy” and that “Proprietary Information

that is not generally known to the software industry or the public is confidential.” Further, Liu

agreed “to exercise diligence at all times to maintain the confidentiality of all confidential

Proprietary Information and not disclose confidential Proprietary Information. [And] I understand

that my obligation to keep Proprietary Information strictly confidential shall survive the termination

of my employment and/or this agreement.”

                The summary judgment record raises a fact issue as to whether Liu violated these

prohibitions by drawing upon his knowledge of Aetna’s business requirements and the complexities

of its agent compensation system, which he originally acquired while working at Trilogy on the DMS

product, in identifying and addressing shortcomings in the Callidus TrueComp product. Viewing

the summary judgment record in the light most favorable to Trilogy, Callidus had not previously

identified those issues and was not likely to do so, at least as quickly as Liu did, and it is reasonable

to infer that Liu would have been unable to so quickly determine the inadequacies of Callidus’s

software to deal with the complexities of Aetna’s need had he not used the customer information that

he had garnered through working on the Aetna account at Trilogy. Liu was prohibited by the PIA

from using or disclosing this information in his work for Callidus. We sustain Trilogy’s issues

regarding its claims that Liu breached his non-disclosure obligations and that Callidus tortiously

interfered with those obligations.

                                                   33
                                         CONCLUSION

               We affirm the trial court’s summary judgment as to Trilogy’s trade secret

misappropriation claims, its claim that Liu violated a non-compete agreement, and its claim that

Callidus tortiously interfered with a non-compete agreement. We reverse the summary judgment

as to Trilogy’s claim that Liu breached his contractual non-disclosure obligations and that Callidus

tortiously interfered with those obligations and remand for further proceedings consistent with this

opinion.

                                              Bob Pemberton, Justice

Before Justices Kidd, B. A. Smith and Pemberton

Affirmed in Part; Reversed and Remanded in Part

Filed: August 12, 2004

                                                34